Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 3/2023

27.10.2022 | Original Research

Barriers for Participation in the Danish Colorectal Cancer Screening Program: a Qualitative Study

verfasst von: Sofie Phillipsen, Louise Kongsmark Weltz, Jannie Dressler, Marie Konge Nielsen, Morten Rasmussen, Lars Nannestad Jorgensen, Anna Thit Johnsen

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The participation rate in the Danish National Screening Program for Colorectal Cancer is around 60%. Since early detection of cancer through the colorectal cancer screening program (CRCS) reduces mortality rates, it is important to understand why people do not participate. The aim of this study was therefore to examine in depth why some people do not participate in the Danish CRCS program.

Methods

Individual semi-structured interviews were conducted with 18 people who had not participated in the national CRCS program. Data was analyzed using an inductive hermeneutic approach.

Results

The analysis uncovered three main themes describing barriers to screening: (a) the accountability for ensuring personal health covered the following sub-themes: (i) when invitation is out of sight it is out of mind, (ii) aversion against own stool sample collection, and (iii) the perceived risk of getting colorectal cancer (CRC); (b) attitudes towards the healthcare system and its organization covered the following sub-themes: (i) positivity towards CRCS, (ii) trust in the healthcare system, (iii) lack of internal communication in the healthcare system, and (iv) wish for involvement of the general practitioner (GP); (c) knowledge about disease and screening covered the following sub-themes: (i) knowledge about CRC and CRCS, (ii) wish for information via new channels, and (iii) CRC is rarely something you talk about.

Conclusion

Among the informants included in this study, lack of participation in the CRCS program was not due to an active opt-out, as most informants had intentions of participating. The informants thought it would motivate them to participate if their GP would remind them of the screening program.
Literatur
11.
17.
Zurück zum Zitat Dahlager S, Fredslund H (2008) Hermeneutic analysis – understanding and pre-understanding. Research methods in public health. Gyldendal akademisk 159–183. Dahlager S, Fredslund H (2008) Hermeneutic analysis – understanding and pre-understanding. Research methods in public health. Gyldendal akademisk 159–183.
18.
Zurück zum Zitat Maxwell JA (2005) Conceptual framework - what do you think is going on? Qualitative research design - an interactive approach, Second Edition ed.: Applied Social Research Methods Series 33–62. Maxwell JA (2005) Conceptual framework - what do you think is going on? Qualitative research design - an interactive approach, Second Edition ed.: Applied Social Research Methods Series 33–62.
22.
Zurück zum Zitat Goodwin BC, March S, Crawford-Williams F, Chambers SK, Dunn J (2020) “I’m not doing that.” An in-depth examination of nonparticipation in mail-out bowel cancer screening programs. Transl Behav Med 1–10. https://doi.org/10.1093/tbm/ibz096 Goodwin BC, March S, Crawford-Williams F, Chambers SK, Dunn J (2020) “I’m not doing that.” An in-depth examination of nonparticipation in mail-out bowel cancer screening programs. Transl Behav Med 1–10. https://​doi.​org/​10.​1093/​tbm/​ibz096
Metadaten
Titel
Barriers for Participation in the Danish Colorectal Cancer Screening Program: a Qualitative Study
verfasst von
Sofie Phillipsen
Louise Kongsmark Weltz
Jannie Dressler
Marie Konge Nielsen
Morten Rasmussen
Lars Nannestad Jorgensen
Anna Thit Johnsen
Publikationsdatum
27.10.2022
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 3/2023
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-022-00876-2

Weitere Artikel der Ausgabe 3/2023

Journal of Gastrointestinal Cancer 3/2023 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.